Imaging Capsule Compton Backscattering Inflamed Area Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiation-based imaging capsules for diagnosing and treating gastrointestinal diseases lack accuracy in identifying inflamed areas within the gastrointestinal tract, which hinders precise treatment delivery.
Innovation Solution
An imaging capsule equipped with a radiation source, collimator, and detectors that use Compton backscattering counts and radiation from radioactively labeled tissue to identify inflamed areas, allowing for targeted scanning and medication release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional imaging capsules are used for gastrointestinal scanning, then basic imaging can be achieved, but accuracy in identifying inflamed areas is insufficient
Solution Approach 1:
The imaging capsule system is segmented into multiple functional modules: radiation source module, collimator module, detector module (including Compton backscattering detector and X-ray fluorescence detector), and processing unit. Each module performs a specific function, allowing the system to achieve high measurement precision for identifying inflamed areas while managing device complexity through modular design.
Solution Approach 2:
The imaging capsule is designed with multi-functionality to address various diagnostic needs. It can detect Compton backscattering radiation, X-ray fluorescence radiation, and potentially other radiation types, enabling it to identify different types of gastrointestinal conditions including inflamed areas, tumors, and structural abnormalities with a single device.
2Measurement precision
If radiation-based imaging is used to scan the gastrointestinal tract, then images can be reconstructed, but precise localization of inflamed areas relative to non-inflamed areas is difficult
Solution Approach 1:
The patent introduces radioactively labeled compounds as intermediaries that selectively accumulate in inflamed areas. These labeled compounds emit characteristic radiation that serves as a mediator between the inflamed tissue and the detectors, enabling precise localization and clear distinction between inflamed and non-inflamed areas through spectral analysis.
Solution Approach 2:
The system utilizes changes in radiation parameters (energy, intensity, scattering angle) to differentiate inflamed from non-inflamed areas. By analyzing the energy spectrum of detected radiation and the angular distribution of Compton backscattering, the system can precisely localize inflamed areas based on distinct radiation signatures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the accuracy of identifying inflamed areas and enables precise treatment delivery by reconstructing images and releasing medication directly to affected regions, improving diagnostic and therapeutic outcomes.
Implementation Method 1
the imaging capsule is configured to identify an inflamed area based on measurements of the detectors in the imaging capsule. For example based on Compton backscattering counts, which are proportional to the density of the surrounding tissue.
Implementation Method 2
At least one detector configured to detect particles resulting from X-ray fluorescence and/or Compton backscattering
Implementation Method 3
the imaging capsule is configured to detect the inflamed area based on detection of radiation from radioactively labeled tissue of the inflamed area
Data Source
AI summary
An imaging capsule including, a radiation source, a collimator that provides a collimated beam from the radiation source, at least one detector configured to detect particles resulting from X-ray fluorescence and/or Compton backscattering in response to the collimated beam to reconstruct images of a user's gastrointestinal tract, wherein the imaging capsule is configured to identify an inflamed area, within the user's gastrointestinal tract, based on a count of the detected particles and initiate actions responsive to detecting the inflamed area.